Related Experiment Video
Updated: Mar 21, 2026

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
Bone Morphogenetic Protein Signaling Is Required for Aortic Valve Calcification
M Victoria Gomez-Stallons1, Elaine E Wirrig-Schwendeman1, Keira R Hassel1
1From the Heart Institute, Cincinnati Children's Hospital Medical Center, OH (M.V.G.-S., E.E.W.-S., K.R.H., K.E.Y.); Department of Pediatrics, College of Medicine, University of Cincinnati, OH (M.V.G.-S., K.E.Y.); and Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN (S.J.C.).
Insights
Bone morphogenetic protein (BMP) signaling drives calcific aortic valve disease (CAVD) by promoting osteochondrogenic gene induction in aortic valve interstitial cells. Inhibiting BMP signaling prevents aortic valve calcification, offering a potential therapeutic target for CAVD.
Area of Science:
- Cardiovascular Biology
- Bone Biology
- Biomaterials Science
Background:
- Calcific aortic valve disease (CAVD) is a prevalent heart valve condition characterized by calcific nodules leading to aortic valve stenosis.
- The underlying mechanisms of CAVD remain largely unknown, though studies suggest a role for bone morphogenetic protein (BMP) signaling.
- Klotho-deficient mice exhibit premature aging and develop aortic valve calcification, mirroring human CAVD.
Purpose of the Study:
- To investigate the role of BMP signaling in the development of CAVD.
- To examine BMP signaling activation and its correlation with calcification in Klotho-deficient mice and porcine aortic valve interstitial cells (VICs).
Main Methods:
- Analysis of pSmad1/5/8 expression in Klotho(-/-) mice to assess BMP signaling activation.
- In vitro studies using porcine VICs treated with osteogenic media.
- Genetic inactivation of the BMP type IA receptor in Klotho(-/-) aortic VICs.
- Inhibition of BMP pathway in osteogenic media-treated VICs.
Main Results:
- BMP signaling activation (pSmad1/5/8 expression) precedes and co-localizes with aortic valve calcification in Klotho(-/-) mice.
- Calcified Klotho(-/-) aortic valves show cellular and extracellular matrix changes resembling bone formation, with increased osteochondrogenic gene expression.
- In vitro, osteogenic media induced BMP pathway activation, osteochondrogenic gene expression, and calcific nodule formation in porcine VICs.
- Genetic inactivation or pharmacological inhibition of BMP signaling in VICs prevented aortic valve calcification.
Conclusions:
- BMP signaling and osteochondrogenic gene induction are active in calcified aortic valves in both Klotho(-/-) mice and porcine VICs.
- BMP signaling is essential for the development of aortic valve calcification in vitro and in vivo.
- Targeting BMP signaling represents a potential therapeutic strategy for CAVD.
Objective:
Calcific aortic valve disease (CAVD) is the most prevalent type of heart valve disease, affecting ≈2% of the US population. CAVD is characterized by the presence of calcific nodules, resulting in aortic valve (AoV) stenosis; however, the underlying mechanisms driving disease remain unknown. Studies of human diseased AoV provide initial evidence that bone morphogenetic protein (BMP) signaling, essential for normal bone formation, is activated during CAVD. Mice deficient in Klotho, an FGF23 transmembrane coreceptor, exhibit premature aging and develop AoV calcific nodules as occurs in human CAVD. The role of BMP signaling in the development of CAVD was examined in porcine aortic valve interstitial cells (VICs) and Klotho(-/-) mice.
Approach And Results:
We show that activation of BMP signaling, as indicated by pSmad1/5/8 expression, precedes and later localizes with AoV calcification in Klotho(-/-) mice. In addition, cellular and extracellular matrix changes resembling features of normal bone formation are accompanied by increased osteochondrogenic gene induction in calcified Klotho(-/-) AoV. Likewise, osteogenic media treatment of porcine VICs results in BMP pathway activation, increased osteochondrogenic gene induction, and formation of calcific nodules in vitro. We demonstrate that genetic inactivation of the BMP type IA receptor in Klotho(-/-) aortic VICs, as well as BMP pathway inhibition of osteogenic media-treated aortic VICs in vitro, results in the inhibition of AoV calcification.
Conclusions:
BMP signaling and osteochondrogenic gene induction are active in calcified Klotho(-/-) AoV in vivo and calcified porcine aortic VICs in vitro. Importantly, BMP signaling is required for the development of AoV calcification in vitro and in vivo.
Related Concept Videos
Bone Formation by Endochondral Ossification
Aortic Regurgitation I: Introduction
Bone Remodeling
Bone Remodeling and Repair
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Bone Formation by Intramembranous Ossification
The process begins when mesenchymal cells in the embryonic skeleton gather together and differentiate into osteogenic cells, which then develop into ...

